O A Minai

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. doi request reprint Clinical characteristics and prediction of pulmonary hypertension in severe emphysema
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care, Cleveland Clinic, USA Electronic address
    Respir Med 108:482-90. 2014
  2. doi request reprint Perioperative risk and management in patients with pulmonary hypertension
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Chest 144:329-40. 2013
  3. doi request reprint Impact of switching from epoprostenol to IV treprostinil on treatment satisfaction and quality of life in patients with pulmonary hypertension
    O A Minai
    Department of Pulmonary, Allergy and Critical Care Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Respir Med 107:458-65. 2013
  4. doi request reprint Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Respir Med 106:1613-21. 2012
  5. doi request reprint Heart rate recovery predicts clinical worsening in patients with pulmonary arterial hypertension
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Am J Respir Crit Care Med 185:400-8. 2012
  6. ncbi request reprint Restless legs syndrome in lung transplant recipients
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care, Cleveland Clinic, Cleveland, Ohio 44195 5038, USA
    J Heart Lung Transplant 26:24-9. 2007
  7. ncbi request reprint Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA
    Chest 131:984-7. 2007
  8. ncbi request reprint Diagnostic strategies for suspected pulmonary arterial hypertension: a primer for the internist
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 74:737-47. 2007
  9. ncbi request reprint Treating pulmonary arterial hypertension: cautious hope in a deadly disease
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 74:789-93, 797-800, 802 passim. 2007
  10. doi request reprint Prevalence and characteristics of restless legs syndrome in patients with pulmonary hypertension
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care Medicine and Sleep Disorders Center, Cleveland Clinic Foundation, Cleveland, Ohio 44195 5038, USA
    J Heart Lung Transplant 27:335-40. 2008

Collaborators

Detail Information

Publications51

  1. doi request reprint Clinical characteristics and prediction of pulmonary hypertension in severe emphysema
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care, Cleveland Clinic, USA Electronic address
    Respir Med 108:482-90. 2014
    ..We explored the prevalence, clinical and physiologic correlates of pulmonary hypertension (PH), and screening strategies in patients with severe emphysema evaluated for the National Emphysema Treatment Trial (NETT)...
  2. doi request reprint Perioperative risk and management in patients with pulmonary hypertension
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Chest 144:329-40. 2013
    ....
  3. doi request reprint Impact of switching from epoprostenol to IV treprostinil on treatment satisfaction and quality of life in patients with pulmonary hypertension
    O A Minai
    Department of Pulmonary, Allergy and Critical Care Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Respir Med 107:458-65. 2013
    ..We conducted a single center, prospective clinical trial to assess the safety, efficacy, and treatment satisfaction of rapidly switching from epoprostenol to IV treprostinil...
  4. doi request reprint Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Respir Med 106:1613-21. 2012
    ..We aimed to evaluate the true impact of altered pulmonary hemodynamics on functional capacity in a cohort of patients with IPF...
  5. doi request reprint Heart rate recovery predicts clinical worsening in patients with pulmonary arterial hypertension
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Am J Respir Crit Care Med 185:400-8. 2012
    ..Reduced heart rate recovery after exercise is associated with increased mortality in cardiopulmonary diseases...
  6. ncbi request reprint Restless legs syndrome in lung transplant recipients
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care, Cleveland Clinic, Cleveland, Ohio 44195 5038, USA
    J Heart Lung Transplant 26:24-9. 2007
    ..We performed a cross-sectional, observational study to determine the prevalence and characteristics of RLS in this population...
  7. ncbi request reprint Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA
    Chest 131:984-7. 2007
    ..To our knowledge, this case represents only the second with a 10-year follow-up reported and demonstrates that aggressive therapy can lead to long-term improvement in clinical parameters and survival...
  8. ncbi request reprint Diagnostic strategies for suspected pulmonary arterial hypertension: a primer for the internist
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 74:737-47. 2007
    ..Before starting treatment, a patient should undergo right heart catheterization to accurately measure the pressures and assess right ventricular function, which help in appropriate selection of therapy...
  9. ncbi request reprint Treating pulmonary arterial hypertension: cautious hope in a deadly disease
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 74:789-93, 797-800, 802 passim. 2007
    ..General internists and specialists in pulmonary, cardiac, and rheumatic diseases each have their role in managing these patients...
  10. doi request reprint Prevalence and characteristics of restless legs syndrome in patients with pulmonary hypertension
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care Medicine and Sleep Disorders Center, Cleveland Clinic Foundation, Cleveland, Ohio 44195 5038, USA
    J Heart Lung Transplant 27:335-40. 2008
    ..Patients with pulmonary hypertension (PH) have an increased prevalence of risk factors for restless legs syndrome (RLS). We performed a cross-sectional study to determine the prevalence and characteristics of RLS in this population...
  11. ncbi request reprint Vaso-active therapy can improve 6-min walk distance in patients with pulmonary hypertension and fibrotic interstitial lung disease
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Respir Med 102:1015-20. 2008
    ..It is not clear whether treatment with newer vaso-active agents benefits patients with PH in the setting of moderate or severe ILD...
  12. doi request reprint Pulmonary hypertension in polymyositis-dermatomyositis: clinical and hemodynamic characteristics and response to vasoactive therapy
    O A Minai
    Department of Pulmonary, Allergy, and Critical Care, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Lupus 18:1006-10. 2009
    ..We report clinical and hemodynamic characteristics and response to vasoactive therapy in three patients with polymyositis-dermatomyositis and pulmonary hypertension and discuss them in light of the available literature...
  13. doi request reprint Frequency and impact of pulmonary hypertension in patients with obstructive sleep apnea syndrome
    Omar A Minai
    Respiratory Institute, Cleveland Clinic, Ohio, USA
    Am J Cardiol 104:1300-6. 2009
    ..Female gender, younger age, obesity, and nocturnal desaturation were associated with PH. PH can cause functional limitations and increased mortality in patients with OSA...
  14. doi request reprint Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective
    Omar A Minai
    Department of Pulmonary and Critical Care Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Chest 137:39S-51S. 2010
    ..The role of PH-specific medications remains poorly defined and requires further study but may be considered in patients with disproportionate PH...
  15. ncbi request reprint Predictors of nocturnal oxygen desaturation in pulmonary arterial hypertension
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA
    Chest 131:109-17. 2007
    ..The study was conducted to determine the prevalence and significance of nocturnal oxygen desaturation in patients with PAH...
  16. ncbi request reprint Surgical intervention in patients with moderate to severe pulmonary arterial hypertension
    Omar A Minai
    Department of Pulmonary anc Critical Care Medicine, Cleveland Clinic Foundation, OH 44195, USA
    Conn Med 70:239-43. 2006
    ..Patients with pulmonary arterial hypertension are believed to experience severe postoperative complications after major surgery...
  17. ncbi request reprint Long-term results after addition of sildenafil in idiopathic PAH patients on bosentan
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    South Med J 99:880-3. 2006
    ..This benefit has been sustained over a mean follow-up period of 19 (range 12-24) months...
  18. ncbi request reprint Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension
    Marie M Budev
    Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Drugs Today (Barc) 40:225-34. 2004
    ....
  19. doi request reprint Pulmonary hypertension in lung diseases: survey of beliefs and practice patterns
    Omar A Minai
    Department of Pulmonary, Allergy, and Critical Care, Cleveland Clinic, Cleveland, OH, USA
    Respir Med 104:741-8. 2010
    ..Pulmonary hypertension can be associated with decreased functional capacity and poor prognosis in patients with parenchymal lung diseases (PLD). Yet, little attention has been given to current beliefs and practice patterns...
  20. doi request reprint Long-term experience after transition from parenteral prostanoids to oral agents in patients with pulmonary hypertension
    Enrique Diaz-Guzman
    Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44124, USA
    Respir Med 102:681-9. 2008
    ..Long-term follow-up after transition to oral agents from parenteral prostanoid therapy has not been well characterized...
  21. ncbi request reprint Treatments and strategies to optimize the comprehensive management of patients with pulmonary arterial hypertension
    Thomas R Gildea
    Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Cleve Clin J Med 70:S18-27. 2003
    ..Knowledge of the supportive therapies, indications for surgical intervention, and emerging drug therapies should provide the working armamentarium for clinicians treating this rare but devastating disease...
  22. ncbi request reprint What risks does a history of pulmonary hypertension present for patients undergoing noncardiac surgery?
    Roop Kaw
    Department of Hospital Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Cleve Clin J Med 74:S20-1. 2007
  23. pmc Natural history of emphysema
    Omar A Minai
    Cleveland Clinic, Cleveland, Ohio, USA
    Proc Am Thorac Soc 5:468-74. 2008
    ..The National Emphysema Treatment Trial has provided additional insight into these features in a large, well-characterized group of patients with severe airflow obstruction and structural emphysema...
  24. ncbi request reprint Lung transplantation for idiopathic pulmonary fibrosis
    David P Mason
    Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Ann Thorac Surg 84:1121-8. 2007
    ....
  25. ncbi request reprint Respiratory failure and sepsis are the major causes of ICU admissions and mortality in survivors of lung transplants
    Celestino Pietrantoni
    Cleveland Clinic Foundation, OH 44195, USA
    Chest 123:504-9. 2003
    ..To identify outcome predictors and prognostic factors in long-term survivors (> 30 days post-transplant) of single-lung and double-lung transplants on readmission to the medical ICU (MICU)...
  26. doi request reprint Bosentan in systemic sclerosis
    Gustavo A Heresi
    Respiratory Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Drugs Today (Barc) 44:415-28. 2008
    ..Bosentan therapy is contraindicated in pregnancy and causes elevated liver transaminases in up to 14% of patients. Hence, monthly pregnancy tests should be performed and hepatic function should be monitored...
  27. ncbi request reprint Implementing a shared-care approach to improve the management of patients with pulmonary arterial hypertension
    Majid M Mughal
    Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Cleve Clin J Med 70:S28-33. 2003
    ..This review describes the contributions of several key specialties to PAH management and outlines the collaborative PAH management model in place at our institution...
  28. ncbi request reprint Pulmonary involvement in Niemann-Pick disease: case report and literature review
    O A Minai
    Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Ohio 44195, USA
    Respir Med 94:1241-51. 2000
    ..This case is unique in that it provides the longest physiological follow-up in the literature, and provides data on the natural history of pulmonary involvement in NPD...
  29. ncbi request reprint Infection control in the bronchoscopy suite. A review
    A C Mehta
    Section of Bronchology, Cleveland Clinic Foundation, Ohio, USA
    Clin Chest Med 20:19-32, ix. 1999
    ....
  30. ncbi request reprint The role of self-expandable metallic stents for the treatment of airway complications after lung transplantation
    Cynthia P Saad
    Department of Pulmonary and Critical Care, The Cleveland Clinic Foundation, Ohio 44195, USA
    Transplantation 75:1532-8. 2003
    ..Different approaches have been used for their nonsurgical management. We describe our experience using self-expandable metallic stents (SEMSs) in patients with airway complications post-LTx...
  31. ncbi request reprint Bronchogenic carcinoma after lung transplantation: characteristics and outcomes
    Omar A Minai
    Departments of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Thorac Oncol 3:1404-9. 2008
    ..Lung cancer may occur in the lung transplant population because many patients are former smokers. Not much is known about risk factors and outcomes in these patients...
  32. doi request reprint BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia
    Christina M Rigelsky
    Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Am J Med Genet A 146:2551-6. 2008
    ..It adds further weight to a common molecular pathogenesis in PAH and HHT, and highlights that BMPR2 gene analysis is indicated in patients affected with both HHT and PAH...
  33. ncbi request reprint Acanthosis nigricans following single lung transplantation: a case report
    Chirag Pandya
    Huron Hospital Cleveland Clinic Health System, Cleveland, Ohio, USA
    Prog Transplant 16:239-41. 2006
    ..Because acanthosis nigricans may occur as a paraneoplastic phenomenon, it is important to rule out an underlying malignancy. This is especially important in solid-organ transplant recipients receiving chronic immunosuppressive therapy...
  34. ncbi request reprint Lupus-associated pulmonary hypertension: long-term response to vasoactive therapy
    Gustavo A Heresi
    Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Respir Med 101:2099-107. 2007
    ..Pulmonary hypertension (PH) is a serious complication of lupus. The effectiveness of current vasoactive therapy has not been well described...
  35. ncbi request reprint A young man with unexplained dyspnea
    Firas Zahr
    Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 73:554-6. 2006
  36. ncbi request reprint Coccidioidomycosis in non-endemic areas: a case series
    S A Desai
    Department of Pulmonary and Critical Care Medicine, Yale University School of Medicine, USA
    Respir Med 95:305-9. 2001
    ..Although coccidioidomycosis is rare in non-endemic areas, physicians must keep it in mind when evaluating patients who have traveled to endemic areas or who are immunosuppressed...
  37. ncbi request reprint Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients
    Hina Sahi
    Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Heart Lung Transplant 26:350-6. 2007
    ..Infection is associated with a high rate of dissemination and poor outcome overall...
  38. doi request reprint Inflammatory myofibroblastic tumor of the lung: recurrence after steroid treatment
    Christopher J Schaeffer
    Section of Thoracic Imaging, Division of Radiology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    J Thorac Imaging 23:191-3. 2008
    ..This is a rare case of inflammatory myofibroblastic tumor recurring poststeroid therapy and adds to the current clinical knowledge about this peculiar manifestation of this disease entity...
  39. ncbi request reprint A 45-year-old woman with systemic lupus erythematosus and progressive dyspnea
    Drew Allen
    Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44124, USA
    Chest 131:1252-5. 2007
  40. doi request reprint Safety of diagnostic bronchoscopy in patients with pulmonary hypertension
    Enrique Diaz-Guzman
    Respiratory Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Respiration 77:292-7. 2009
    ..Although previous reports suggest that transbronchial biopsies increase the risk for hemorrhage in this population, data are limited to survey analyses and isolated reports...
  41. ncbi request reprint Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial
    Gerald Simonneau
    Service de Pneumologie, Hopital Antoine Beclere, Universite Paris Sud, Clamart, France
    Ann Intern Med 149:521-30. 2008
    ..Oral sildenafil and intravenous epoprostenol have independently been shown to be effective in patients with pulmonary arterial hypertension...
  42. ncbi request reprint Lung transplantation in a patient with Mounier-Kuhn syndrome
    Omar A Minai
    J Thorac Cardiovasc Surg 132:737-8. 2006
  43. pmc Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema
    Gerard J Criner
    Pulmonary and Critical Care Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA
    Am J Respir Crit Care Med 176:253-60. 2007
    ..To determine the effect of medical treatment versus lung volume reduction surgery (LVRS) on pulmonary hemodynamics...
  44. pmc Overview of the perioperative management of lung volume reduction surgery patients
    Amir Sharafkhaneh
    Division of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    Proc Am Thorac Soc 5:438-41. 2008
    ..Aggressive management of early postoperative complications, including air leaks, respiratory failure, arrhythmias, and hemorrhage, can also be expected to improve outcomes...
  45. ncbi request reprint Race as an independent prognostic factor in patients with idiopathic pulmonary arterial hypertension
    Omar A Minai
    Am J Cardiol 96:740. 2005
  46. ncbi request reprint Referral for lung transplantation: a moving target
    Omar A Minai
    Chest 127:705-7. 2005
  47. ncbi request reprint Pulmonary nodules in lung transplant recipients: etiology and outcome
    Pyng Lee
    Department of Respiratory Medicine and Critical Care Medicine, Singapore General Hospital, Singapore
    Chest 125:165-72. 2004
    ..Common causes of PNs in lung transplant (LT) recipients include bacterial or fungal infections and posttransplant lymphoproliferative disorder (PTLD). However, experience in diagnosis and management of PNs is limited...
  48. pmc The evaluation and preparation of the patient for lung volume reduction surgery
    Malcolm M Decamp
    Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Proc Am Thorac Soc 5:427-31. 2008
    ..Optimal candidates have upper-lobe-predominant emphysema and acceptable operative risks...
  49. pmc Comorbidities in chronic obstructive pulmonary disease
    Wissam M Chatila
    Division of Pulmonary and Critical Care Division, Temple University School of Medicine, 3401 N Broad Street, Philadelphia PA, 19140, USA
    Proc Am Thorac Soc 5:549-55. 2008
    ....
  50. pmc Cardiac disease in chronic obstructive pulmonary disease
    Jeremy A Falk
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars Sinai Medical Center, for the David Geffen School of Medicine at UCLA, Los Angeles, California, USA
    Proc Am Thorac Soc 5:543-8. 2008
    ..Use of beta-blockers in the management of cardiac disease, while a theoretical concern in patients with increased airway resistance, is generally safe with the use of cardioselective agents...
  51. pmc Sleep abnormalities and treatment in emphysema
    SAMUEL KRACHMAN
    Sleep Disorders Center, Division of Pulmonary and Critical Care, Temple University School of Medicine, Philadelphia, PA 19140, USA
    Proc Am Thorac Soc 5:536-42. 2008
    ..Future studies investigating disease mechanism and response to therapy in patients with sleep abnormalities and severe emphysema are warranted...